Showing 1 - 7 results of 7 for search 'Dustin L Williams', query time: 0.03s Refine Results
  1. 1
    Comparison of Staphylococcus aureus tolerance between antimicrobial blue light, levofloxacin, and rifampin

    Comparison of Staphylococcus aureus tolerance between antimicrobial blue light, levofloxacin, and rifampin by Jemi Ong, Jemi Ong, Rose Godfrey, Alexa Nazarian, Joshua Tam, Joshua Tam, Brad M. Isaacson, Brad M. Isaacson, Brad M. Isaacson, Brad M. Isaacson, Paul F. Pasquina, Paul F. Pasquina, Dustin L. Williams, Dustin L. Williams, Dustin L. Williams, Dustin L. Williams

    Published 2023-05-01
    Get full text
    Article
  2. 2
    A Porcine Model for the Development and Testing of Preoperative Skin Preparations

    A Porcine Model for the Development and Testing of Preoperative Skin Preparations by Hannah R. Duffy, Rose W. Godfrey, Dustin L. Williams, Nicholas N. Ashton

    Published 2022-04-01
    Get full text
    Article
  3. 3
    Optimal dose of lactoferrin reduces the resilience of in vitro Staphylococcus aureus colonies.

    Optimal dose of lactoferrin reduces the resilience of in vitro Staphylococcus aureus colonies. by Jagir R Hussan, Stuart G Irwin, Brya Mathews, Simon Swift, Dustin L Williams, Jillian Cornish

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Development and validation of a large animal ovine model for implant-associated spine infection using biofilm based inocula

    Development and validation of a large animal ovine model for implant-associated spine infection using biofilm based inocula by Jeremy D. Shaw, Travis L. Bailey, Jemi Ong, Darrel S. Brodke, Dustin L. Williams, Richard A. Wawrose, Richard T. Epperson, Brooke Kawaguchi, Nicholas N. Ashton

    Published 2023-12-01
    Get full text
    Article
  5. 5
    Examination of a first-in-class bis-dialkylnorspermidine-terphenyl antibiotic in topical formulation against mono and polymicrobial biofilms.

    Examination of a first-in-class bis-dialkylnorspermidine-terphenyl antibiotic in topical formulation against mono and polymicrobial biofilms. by Mariël Miller, Jeffery C Rogers, Marissa A Badham, Lousili Cadenas, Eian Brightwell, Jacob Adams, Cole Tyler, Paul R Sebahar, Travis J Haussener, Hariprasada Reddy Kanna Reddy, Ryan E Looper, Dustin L Williams

    Published 2020-01-01
    Get full text
    Article
  6. 6
    Ex vivo comparison of V.A.C.® Granufoam Silver™ and V.A.C.® Granufoam™ loaded with a first-in-class bis-dialkylnorspermidine-terphenyl antibiofilm agent

    Ex vivo comparison of V.A.C.® Granufoam Silver™ and V.A.C.® Granufoam™ loaded with a first-in-class bis-dialkylnorspermidine-terphenyl antibiofilm agent by Kaden B. Rawson, Travis Neuberger, Tyler B. Smith, Isaac J. Bell, Ryan E. Looper, Paul R. Sebahar, Travis J. Haussener, Hariprasada Reddy Kanna Reddy, Brad M. Isaacson, John Shero, Paul F. Pasquina, Dustin L. Williams

    Published 2023-12-01
    Get full text
    Article
  7. 7
    In vivo efficacy of a unique first-in-class antibiofilm antibiotic for biofilm-related wound infections caused by Acinetobacter baumannii

    In vivo efficacy of a unique first-in-class antibiofilm antibiotic for biofilm-related wound infections caused by Acinetobacter baumannii by Dustin L. Williams, Brooke Kawaguchi, Nicholas B. Taylor, Gina Allyn, Marissa A. Badham, Jeffery C. Rogers, Brittany R. Peterson, Paul R. Sebahar, Travis J. Haussener, Hariprasada Reddy Kanna Reddy, Brad M. Isaacson, Paul F. Pasquina, Ryan E. Looper

    Published 2020-12-01
    Get full text
    Article

Search Tools: